CN103550718B - A kind of Chinese medicine composition for the treatment of pulmonary carcinoma - Google Patents
A kind of Chinese medicine composition for the treatment of pulmonary carcinoma Download PDFInfo
- Publication number
- CN103550718B CN103550718B CN201310575541.2A CN201310575541A CN103550718B CN 103550718 B CN103550718 B CN 103550718B CN 201310575541 A CN201310575541 A CN 201310575541A CN 103550718 B CN103550718 B CN 103550718B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 241000756943 Codonopsis Species 0.000 claims abstract description 14
- 241000628997 Flos Species 0.000 claims abstract description 14
- 241001312741 Gekko swinhonis Species 0.000 claims abstract description 14
- 239000009636 Huang Qi Substances 0.000 claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 14
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 14
- 241000131808 Scolopendra Species 0.000 claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 14
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 14
- 239000002775 capsule Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 238000012546 transfer Methods 0.000 abstract description 2
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 206010028980 Neoplasm Diseases 0.000 description 16
- 239000012567 medical material Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000000284 extract Substances 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 7
- 208000020816 lung neoplasm Diseases 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 6
- 201000005202 lung cancer Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010008479 Chest Pain Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 3
- 229960004316 cisplatin Drugs 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010041067 Small cell lung cancer Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000010827 pathological analysis Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 208000000587 small cell lung carcinoma Diseases 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027452 Metastases to bone Diseases 0.000 description 1
- 206010027457 Metastases to liver Diseases 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000024753 bloody sputum Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 201000005243 lung squamous cell carcinoma Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001830 phrenic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Abstract
The invention provides a kind of Chinese medicine composition for the treatment of pulmonary carcinoma, be made up of agents: Radix Codonopsis, Gekko Swinhonis, Rhizoma Curcumae, Radix Notoginseng, Radix Platycodonis, the Radix Astragali, Bulbus Fritillariae Cirrhosae, Lignum Aquilariae Resinatum, Fructus Crataegi, Scolopendra, Semen Armeniacae Amarum, Rhizoma Coptidis, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Rhizoma Dioscoreae, Radix Rehmanniae part, Radix Ophiopogonis, Cortex Moutan, Flos Carthami, Herba Hedyotidis Diffusae, Herba Houttuyniae, Radix Sophorae Tonkinensis.Medicine in line with righting be main, take into account the dialectical principle of eliminating evil, efficacy enhancing and toxicity reducing, emphasis, for transfer patient resistance against diseases, anticancer increases successful, have evident in efficacy, cost is low, instant effect, the advantage had no side effect.
Description
Technical field
The present invention arranges a kind of Chinese medicine composition of Therapeutic cancer, particularly a kind of Chinese medicine composition for the treatment of pulmonary carcinoma.
Background technology
Pulmonary carcinoma is primary in bronchial epithelial malignant tumor at different levels.Pulmonary carcinoma case fatality rate shelter has first of cancer, and sickness rate has the trend increased year by year, has occupied the first place of malignant tumor in some large-and-medium size cities of many developed countries and China.The common symptom of pulmonary carcinoma is cough, chest pain, hemoptysis, heating etc., to cough and bloody sputum is common early symptom.The early stage of lung cancer can adopt operation means, but Most patients is made a definite diagnosis and is in middle and advanced stage, and adopt the means treatment of radiation and chemotherapy, easily cause respiratory tract, cardiovascular complication, treatment side effect is large, and recurrence and metastatic rate is high.
Pulmonary carcinoma overall treatment effect is poor, and within 5 years, survival rate is only 15%-17%.Along with the recent years of deepening continuously to the research for the treatment of by Chinese herbs pulmonary carcinoma, Chinese medicine plays more and more important effect in treatment pulmonary carcinoma.The present invention in line with righting be main, take into account the dialectical principle of eliminating evil, efficacy enhancing and toxicity reducing, emphasis, provide a kind of Chinese medicine composition for the treatment of pulmonary carcinoma, it is evident in efficacy, cost is low, instant effect, substantially nontoxic negative (pair) acts on.
Summary of the invention
For problems of the prior art, the invention provides a kind of Chinese medicine composition for the treatment of pulmonary carcinoma.
The Chinese medicine composition for the treatment of pulmonary carcinoma provided by the invention, be made up of following mixing ratio by weight material medicine: Radix Codonopsis 20-30 part, Gekko Swinhonis 20-30 part, Rhizoma Curcumae 10-15 part, Radix Notoginseng 10-20 part, Radix Platycodonis 20-30 part, Radix Astragali 20-25 part, Bulbus Fritillariae Cirrhosae 10-15 part, Lignum Aquilariae Resinatum 10-15 part, Fructus Crataegi 10-15 part, Scolopendra 5-10 part, Semen Armeniacae Amarum 10-15 part, Rhizoma Coptidis 10-15 part, Rhizoma Atractylodis Macrocephalae 5-10 part, Radix Glycyrrhizae 5-10 part, Rhizoma Dioscoreae 5-15 part, Radix Rehmanniae 10-15 part, Radix Ophiopogonis 10-15 part, Cortex Moutan 10-15 part, Flos Carthami 10-15 part, Herba Hedyotidis Diffusae 20-30 part, Herba Houttuyniae 10-15 part, Radix Sophorae Tonkinensis 10-15 part.
Preferred Chinese medicine composition, the weight proportion of each component is: Radix Codonopsis 30 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 10 parts, Radix Notoginseng 17 parts, Radix Platycodonis 28 parts, the Radix Astragali 20 parts, Bulbus Fritillariae Cirrhosae 12 parts, Lignum Aquilariae Resinatum 12 parts, Fructus Crataegi 15 parts, Scolopendra 7 parts, 12 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 15 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, 6 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 6 parts, Radix Rehmanniae 12 parts, Radix Ophiopogonis 12 parts, Cortex Moutan 12 parts, 10 parts, Flos Carthami, Herba Hedyotidis Diffusae 23 parts, Herba Houttuyniae 12 parts, Radix Sophorae Tonkinensis 12 parts.
Preferred Chinese medicine composition, the ratio of each component is: Radix Codonopsis 20 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 15 parts, Radix Notoginseng 15 parts, Radix Platycodonis 25 parts, the Radix Astragali 22 parts, Bulbus Fritillariae Cirrhosae 10 parts, Lignum Aquilariae Resinatum 10 parts, Fructus Crataegi 15 parts, Scolopendra 7 parts, 12 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 15 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, 6 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 6 parts, Radix Rehmanniae 12 parts, Radix Ophiopogonis 15 parts, Cortex Moutan 15 parts, 10 parts, Flos Carthami, Herba Hedyotidis Diffusae 20 parts, Herba Houttuyniae 10 parts, Radix Sophorae Tonkinensis 10 parts.
Preferred Chinese medicine composition, the ratio of each component is: Radix Codonopsis 30 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 15 parts, Radix Notoginseng 15 parts, Radix Platycodonis 30 parts, the Radix Astragali 25 parts, Bulbus Fritillariae Cirrhosae 10 parts, Lignum Aquilariae Resinatum 10 parts, Fructus Crataegi 13 parts, Scolopendra 10 parts, 13 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 13 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 13 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 13 parts, Radix Rehmanniae 13 parts, Radix Ophiopogonis 13 parts, Cortex Moutan 13 parts, 13 parts, Flos Carthami, Herba Hedyotidis Diffusae 30 parts, Herba Houttuyniae 15 parts, Radix Sophorae Tonkinensis 10 parts.
The Chinese medicine composition of pulmonary carcinoma is treated in the present invention, wherein Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Semen Armeniacae Amarum, the righting of Lignum Aquilariae Resinatum QI invigorating, Scolopendra, Gekko Swinhonis, Herba Hedyotidis Diffusae, Radix Sophorae Tonkinensis, Rhizoma Coptidis, Herba Houttuyniae detoxicating and fighting cancer, Radix Notoginseng, Flos Carthami, Rhizoma Curcumae, Fructus Crataegi blood circulation promoting and blood stasis dispelling, Radix Platycodonis, Radix Rehmanniae, Bulbus Fritillariae Cirrhosae, Radix Glycyrrhizae, Radix Ophiopogonis, Cortex Moutan, Rhizoma Dioscoreae moistening the lung and resolving phlegm.Above-mentionedly importantly to complement each other, cooperatively interact, effect of QI invigorating righting, detoxicating and fighting cancer, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, moistening the lung and resolving phlegm can be played.Therapeutical effect is significantly had to pulmonary carcinoma in clinical.
Chinese medicine composition in the present invention can be prepared into conventional oral formulations with the method for Chinese medicinal of routine, such as tablet, pill, powder, capsule etc.
Detailed description of the invention
Embodiment one:
One treats pulmonary carcinoma Chinese medicine composition, the weight proportion of each component is: Radix Codonopsis 30 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 10 parts, Radix Notoginseng 17 parts, Radix Platycodonis 28 parts, the Radix Astragali 20 parts, Bulbus Fritillariae Cirrhosae 12 parts, Lignum Aquilariae Resinatum 12 parts, Fructus Crataegi 15 parts, Scolopendra 7 parts, 12 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 15 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, 6 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 6 parts, Radix Rehmanniae 12 parts, Radix Ophiopogonis 12 parts, Cortex Moutan 12 parts, 10 parts, Flos Carthami, Herba Hedyotidis Diffusae 23 parts, Herba Houttuyniae 12 parts, Radix Sophorae Tonkinensis 12 parts.
Get whole medical material, extracting in water twice, the water that first time adds medical material gross weight 7 times, extract 3 hours, second time adds the water of medical material 6 times, extracts 2 hours; Merge extractive liquid, when being concentrated into 80 DEG C, relative density is the extractum of 1.24, and adding ethanol to the concentration of volume percent of alcohol content is 56%, stir even, leave standstill 18 hours, filter, when filtrate is concentrated into 80 DEG C, relative density is the extractum of 1.23, obtains described active component; Mixed with appropriate amount of starch and dextrin by active component, granulate, dry, tabletting, obtains tablet of the present invention.
Embodiment two:
One treats pulmonary carcinoma Chinese medicine composition, the weight proportion of each component is: Radix Codonopsis 30 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 10 parts, Radix Notoginseng 17 parts, Radix Platycodonis 28 parts, the Radix Astragali 20 parts, Bulbus Fritillariae Cirrhosae 12 parts, Lignum Aquilariae Resinatum 12 parts, Fructus Crataegi 15 parts, Scolopendra 7 parts, 12 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 15 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, 6 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 6 parts, Radix Rehmanniae 12 parts, Radix Ophiopogonis 12 parts, Cortex Moutan 12 parts, 10 parts, Flos Carthami, Herba Hedyotidis Diffusae 23 parts, Herba Houttuyniae 12 parts, Radix Sophorae Tonkinensis 12 parts.
Get whole medical material, extracting in water twice, the water that first time adds medical material gross weight 6 times, extract 3 hours, second time adds the water of medical material 5 times, extracts 2 hours; Merge extractive liquid, when being concentrated into 80 DEG C, relative density is the extractum of 1.27, and adding ethanol to the concentration of volume percent of alcohol content is 50%, stir even, leave standstill 18 hours, filter, when filtrate is concentrated into 80 DEG C, relative density is the extractum of 1.24, obtains described active component; Active component to be put in vacuum drying oven 70 DEG C and dry, pulverize 200 mesh sieves, add appropriate amount of starch, silicon dioxide, magnesium stearate, make granule, dry, incapsulate, obtain capsule of the present invention.
Embodiment three:
One treats pulmonary carcinoma Chinese medicine composition, the weight proportion of each component is: Radix Codonopsis 20 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 15 parts, Radix Notoginseng 15 parts, Radix Platycodonis 25 parts, the Radix Astragali 22 parts, Bulbus Fritillariae Cirrhosae 10 parts, Lignum Aquilariae Resinatum 10 parts, Fructus Crataegi 15 parts, Scolopendra 7 parts, 12 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 15 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, 6 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 6 parts, Radix Rehmanniae 12 parts, Radix Ophiopogonis 15 parts, Cortex Moutan 15 parts, 10 parts, Flos Carthami, Herba Hedyotidis Diffusae 20 parts, Herba Houttuyniae 10 parts, Radix Sophorae Tonkinensis 10 parts.
Get whole medical material, extracting in water twice, the water that first time adds medical material gross weight 7 times, extract 3 hours, second time adds the water of medical material 6 times, extracts 2 hours; Merge extractive liquid, when being concentrated into 80 DEG C, relative density is the extractum of 1.24, and adding ethanol to the concentration of volume percent of alcohol content is 56%, stir even, leave standstill 18 hours, filter, when filtrate is concentrated into 80 DEG C, relative density is the extractum of 1.23, obtains described active component; Mixed with appropriate amount of starch and dextrin by active component, granulate, dry, tabletting, obtains tablet of the present invention.
Embodiment four:
One treats pulmonary carcinoma Chinese medicine composition, the weight proportion of each component is: Radix Codonopsis 20 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 15 parts, Radix Notoginseng 15 parts, Radix Platycodonis 25 parts, the Radix Astragali 22 parts, Bulbus Fritillariae Cirrhosae 10 parts, Lignum Aquilariae Resinatum 10 parts, Fructus Crataegi 15 parts, Scolopendra 7 parts, 12 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 15 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, 6 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 6 parts, Radix Rehmanniae 12 parts, Radix Ophiopogonis 15 parts, Cortex Moutan 15 parts, 10 parts, Flos Carthami, Herba Hedyotidis Diffusae 20 parts, Herba Houttuyniae 10 parts, Radix Sophorae Tonkinensis 10 parts.
Get whole medical material, extracting in water twice, the water that first time adds medical material gross weight 6 times, extract 3 hours, second time adds the water of medical material 5 times, extracts 2 hours; Merge extractive liquid, when being concentrated into 80 DEG C, relative density is the extractum of 1.27, and adding ethanol to the concentration of volume percent of alcohol content is 50%, stir even, leave standstill 18 hours, filter, when filtrate is concentrated into 80 DEG C, relative density is the extractum of 1.24, obtains described active component; Active component to be put in vacuum drying oven 70 DEG C and dry, pulverize 200 mesh sieves, add appropriate amount of starch, silicon dioxide, magnesium stearate, make granule, dry, incapsulate, obtain capsule of the present invention.
Embodiment five:
One treats pulmonary carcinoma Chinese medicine composition, the weight proportion of each component is: Radix Codonopsis 30 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 15 parts, Radix Notoginseng 15 parts, Radix Platycodonis 30 parts, the Radix Astragali 25 parts, Bulbus Fritillariae Cirrhosae 10 parts, Lignum Aquilariae Resinatum 10 parts, Fructus Crataegi 13 parts, Scolopendra 10 parts, 13 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 13 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 13 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 13 parts, Radix Rehmanniae 13 parts, Radix Ophiopogonis 13 parts, Cortex Moutan 13 parts, 13 parts, Flos Carthami, Herba Hedyotidis Diffusae 30 parts, Herba Houttuyniae 15 parts, Radix Sophorae Tonkinensis 10 parts.
Get whole medical material, extracting in water twice, the water that first time adds medical material gross weight 7 times, extract 3 hours, second time adds the water of medical material 6 times, extracts 2 hours; Merge extractive liquid, when being concentrated into 80 DEG C, relative density is the extractum of 1.24, and adding ethanol to the concentration of volume percent of alcohol content is 56%, stir even, leave standstill 18 hours, filter, when filtrate is concentrated into 80 DEG C, relative density is the extractum of 1.23, obtains described active component; Mixed with appropriate amount of starch and dextrin by active component, granulate, dry, tabletting, obtains tablet of the present invention.
Instructions of taking: in the present invention, the instructions of taking of all kinds of medicament is as follows: tablet: every day three times, one after each meal, each 3-5 sheet, every sheet content of dispersion 0.4 gram; Capsule: every day three times, one after each meal, each 3-5 grain, every content of dispersion 0.4 gram.The course for the treatment of in January one, amount to 8 courses for the treatment of.
Chinese medicine composition of the present invention is to the inhibitory action of the solid tumor of the mice of oxter plantation lung cancer Lewis tumor strain.
Experiment material: the Chinese medicine composition in the embodiment of the present invention one; Normal saline; Cisplatin; SPF level KM mice 60, male and female half and half, 4 week age, 18.0-22.0g.Divide into groups according to completely random group technology; Male and female are divided into groups respectively.
Experimental technique: mice lung cancer Lewis tumor strain cell culture in RPMI-1640,37 DEG C, 5%CO
2lower cellar culture, on average goes down to posterity once in every two days, and being prepared into density to normal saline during exponential phase is 3.0 × 10
7individual/ml single cell suspension, aseptically be injected in mouse peritoneal, inoculate latter 7 days and see the obvious enlargement of mouse peritoneal, now, de-neck is put to death, and puts into the beaker filling 75% ethanol and soaks 2 ~ 3 minutes, the mice after sterilization is put into superclean bench, expose abdominal part, put into aseptic reagent bottle by asepsis injector extraction ascites for subsequent use.Above-mentioned ascites trypan blue is counted, with normal saline dilution, adjustment cell number to 1.0 × 10
7individual/ml, is inoculated in the right oxter of mice, every 0.4ml.
Dosage and mode: model group, give normal saline; Matched group, gives cisplatin 0.1mg/20g mice, lumbar injection d1,3,5; The heavy dose of group of Chinese medicine of the present invention, by 15mg/kg gavage; Dosage group in Chinese medicine of the present invention, by 10mg/kg gavage; Chinese medicine small dose group of the present invention, by 5mg/kg gavage.Continuous gavage 14 days except cisplatin, every day 1 time, gavage solvent 15ml/kg.
Within 15th day, put to death mice, dissect and peel off tumor block, claim tumor weight, calculate tumour inhibiting rate.Tumour inhibiting rate=(1-T/C) × 100%, formulae discovery tumour inhibiting rate, in formula, T is the average tumor weight of administration group, and C is the average tumor weight of matched group.
Result of the test: heavy dose of, middle dosage group and small dose group all have the tumor growth effect suppressing Lewis lung cancer mice, and tumor is heavily alleviated, wherein heavy dose of group, middle dosage group and small dose group tumour inhibiting rate reach 59.68%, 52.76% and 42.01% respectively.
Clinical case.Case 1, female, 47 years old, patient's pale complexion, dry cough, low grade fever, uncomfortable in chest, chest pain, lung CT is shown in bottom right lung neoplasms 4cm × 5cm, and vertical phrenic lymph nodes transfer, fibre bronchus mirror's definitive pathological diagnosis is pulmonary carcinoma, and pathology is adenocarcinoma of lung.Take the medicine of embodiment 1 after 1 month, spirit is got better, and uncomfortable in chest, chest pain symptom alleviates.After taking 4 courses for the treatment of, check CT is shown in that pulmonary lump reduces 50%.Chinese medicine takes 3 years, survives 41 months, after die from lung cancer with brain metastasis.
Case 2, man, 42 years old, patient coughed, become thin, uncomfortable in chest, weak, and lung CT is shown in left upper lobe of lung central type carcinoma of lung, lump 6cm × 6cm, and pathology is squamous cell lung carcinoma.After taking 4 courses for the treatment of of drug administration of embodiment two, check CT is shown in that pulmonary lump reduces 60%.Drug administration 2 years, survives 30 months, after die from bone metastases of lung cancer.
Case 3, man, 59 years old, patient's shortness of breath and fatigue, cough, cough with blood-flecked phlegm silk, uncomfortable in chest.Lung CT is shown in lower right lobe central type carcinoma of lung, lump 5cm × 6cm, and pathology is small cell lung cancer.Take the medicine of embodiment three when chemotherapy starts, after taking 4 courses for the treatment of, check CT is shown in that pulmonary lump reduces 30%.Adhere to taking 10 months, patient experiences stable disease at present.
Case 4, man, 39 years old, patient's cough with asthma, shortness of breath and fatigue, uncomfortable in chest, cough with blood-flecked phlegm silk.Lung CT is shown in upper right lobe of the lung central type carcinoma of lung, lump 7cm × 6cm, lymph enlargement on right clavicle, and pathological diagnosis is adenocarcinoma of lung.Chemotherapy 6 all after dates, take the medicine of embodiment four during beginning, after taking 9 months, patient dies from hepatic metastases.
Case 5, female, 51 years old, patient generated heat, and cough is uncomfortable in chest, cough with blood-flecked phlegm silk.Lung CT is shown in left lobe central type carcinoma of lung, lump 5cm × 4cm, and pathology is small cell lung cancer.Take the medicine of embodiment five, after taking 4 courses for the treatment of, check CT is shown in that pulmonary lump is eliminated substantially, and appetite strengthens.Take 21 months, patient experiences stable disease at present.
In recent years, totally 142 routine patients take the Chinese medicine for the treatment of pulmonary carcinoma of the present invention, through the treatment of certain hour, cure 13 examples, and obvious 46 examples of therapeutic effect, treat 50 effective examples, (effective 46 examples, stable disease 50 example) invalid 33 examples.After most of patients takes Chinese medicine, combined treatment, symptom is obviously improved, and achieves good therapeutic effect.
Claims (4)
1. treat the Chinese medicine composition of pulmonary carcinoma for one kind, it is characterized in that: be only made up of following mixing ratio by weight material medicine: Radix Codonopsis 20-30 part, Gekko Swinhonis 20-30 part, Rhizoma Curcumae 10-15 part, Radix Notoginseng 10-20 part, Radix Platycodonis 20-30 part, Radix Astragali 20-25 part, Bulbus Fritillariae Cirrhosae 10-15 part, Lignum Aquilariae Resinatum 10-15 part, Fructus Crataegi 10-15 part, Scolopendra 5-10 part, Semen Armeniacae Amarum 10-15 part, Rhizoma Coptidis 10-15 part, Rhizoma Atractylodis Macrocephalae 5-10 part, Radix Glycyrrhizae 5-10 part, Rhizoma Dioscoreae 5-15 part, Radix Rehmanniae 10-15 part, Radix Ophiopogonis 10-15 part, Cortex Moutan 10-15 part, Flos Carthami 10-15 part, Herba Hedyotidis Diffusae 20-30 part, Herba Houttuyniae 10-15 part, Radix Sophorae Tonkinensis 10-15 part.
2. the Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, it is characterized in that: the weight proportion of each component is: Radix Codonopsis 30 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 10 parts, Radix Notoginseng 17 parts, Radix Platycodonis 28 parts, the Radix Astragali 20 parts, Bulbus Fritillariae Cirrhosae 12 parts, Lignum Aquilariae Resinatum 12 parts, Fructus Crataegi 15 parts, Scolopendra 7 parts, 12 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 15 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, 6 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 6 parts, Radix Rehmanniae 12 parts, Radix Ophiopogonis 12 parts, Cortex Moutan 12 parts, 10 parts, Flos Carthami, Herba Hedyotidis Diffusae 23 parts, Herba Houttuyniae 12 parts, Radix Sophorae Tonkinensis 12 parts.
3. the Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, it is characterized in that: the weight proportion of each component is: Radix Codonopsis 20 parts, Gekko Swinhonis 20 parts, Rhizoma Curcumae 15 parts, Radix Notoginseng 15 parts, Radix Platycodonis 25 parts, the Radix Astragali 22 parts, Bulbus Fritillariae Cirrhosae 10 parts, Lignum Aquilariae Resinatum 10 parts, Fructus Crataegi 15 parts, Scolopendra 7 parts, 12 parts, Semen Armeniacae Amarum, Rhizoma Coptidis 15 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, 6 parts, Radix Glycyrrhizae, Rhizoma Dioscoreae 6 parts, Radix Rehmanniae 12 parts, Radix Ophiopogonis 15 parts, Cortex Moutan 15 parts, 10 parts, Flos Carthami, Herba Hedyotidis Diffusae 20 parts, Herba Houttuyniae 10 parts, Radix Sophorae Tonkinensis 10 parts.
4. as described in any one of claim 2 to 3, treat the Chinese medicine composition of pulmonary carcinoma, can make and become tablet, capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310575541.2A CN103550718B (en) | 2013-11-18 | 2013-11-18 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310575541.2A CN103550718B (en) | 2013-11-18 | 2013-11-18 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103550718A CN103550718A (en) | 2014-02-05 |
| CN103550718B true CN103550718B (en) | 2015-08-05 |
Family
ID=50005191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310575541.2A Expired - Fee Related CN103550718B (en) | 2013-11-18 | 2013-11-18 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103550718B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105213911A (en) * | 2015-10-30 | 2016-01-06 | 山东省立医院 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
| CN105687839A (en) * | 2016-02-29 | 2016-06-22 | 李朝彬 | Traditional Chinese medicine composition for treating lung cancer, cough and hemoptysis |
| CN105920502A (en) * | 2016-06-29 | 2016-09-07 | 贵州中草医医院 | Traditional Chinese medicinal composition for treating lung cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1054289C (en) * | 1994-07-01 | 2000-07-12 | 柳毅 | Medicine for curing tumour |
| CN101049484A (en) * | 2007-05-14 | 2007-10-10 | 郝来勤 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
| CN101966310B (en) * | 2010-09-27 | 2011-11-09 | 陈树亮 | Traditional Chinese medicine for treating lung cancer |
-
2013
- 2013-11-18 CN CN201310575541.2A patent/CN103550718B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103550718A (en) | 2014-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041312B (en) | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof | |
| CN100428949C (en) | Anticancer taxad Chinese medicine prepn | |
| CN106390013A (en) | Compound traditional Chinese medicine composition capable of inhibiting colorectal liver metastases as well as preparation method and application thereof | |
| CN106421383A (en) | Anticancer traditional Chinese medicine composition | |
| CN102008650B (en) | Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof | |
| CN104352608A (en) | Traditional Chinese medicine capable of benefiting qi, activating blood circulation, softening hardness, dissipating stagnation, realizing detoxification and relieving pain as well as preparation method thereof | |
| CN104491740A (en) | Traditional Chinese medicine composition for treating liver cancer and preparation method of traditional Chinese medicine composition | |
| CN102114099B (en) | Traditional Chinese medicine preparation for inhibiting liver cancer and preparation method thereof | |
| CN102861284A (en) | Traditional Chinese medicine compound preparation for treating non-small cell lung cancer and preparation method thereof | |
| CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN103550718B (en) | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma | |
| CN102688317B (en) | Traditional Chinese medicine for treating liver cancer | |
| CN102247479B (en) | Antitumor strong medicine and preparation method thereof | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN101564464B (en) | Chinese medicament for adjusting organism immunity of tumor patients | |
| CN102872385B (en) | Compound Chinese medicinal composition for treating advanced gastric cancer and preparation method and application thereof | |
| CN104189782A (en) | Anti-tumor medicament composition | |
| CN105596890A (en) | Method for preparing traditional Chinese medicine composition for treating lung cancer | |
| CN103768519B (en) | A kind of compound medicine improving cyclophosphamide antitumor curative effect and preparation method thereof | |
| CN104888128A (en) | Traditional Chinese medicine composition for treatment of cancers | |
| CN100411663C (en) | Anticancer compound Chinese medicine powder and its preparing method | |
| CN104383349A (en) | Drug for postoperative recovery of bladder cancer and preparation method of drug for postoperative recovery of bladder cancer | |
| CN103432282A (en) | Compound medicine for treating tumor | |
| CN102940773A (en) | Chinese medicinal preparation for inhibiting liver cancer metastasis and preparation method thereof | |
| CN114869987B (en) | Traditional Chinese medicine composition for preventing liver cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: YANGZHOU GUOWEI BIO-TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LIANG YICONG Effective date: 20150609 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Junde Inventor before: Liang Diecong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIANG YICONG TO: LIU JUNDE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150609 Address after: 225000, Ding Xing Road 89, Tang Wang science and Technology Industrial Zone, Guangling District, Jiangsu, Yangzhou Applicant after: Guo Wei bio tech ltd, Yangzhou Address before: 250000 Shandong City, Ji'nan, No. ten via road 4, building 4, unit 25156, 402 Applicant before: Liang Diecong |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150805 Termination date: 20191118 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |